Tresiba is a prescription drug approved by the Food and Drug Administration (FDA) to treat type 2 diabetes in adults. Tresiba is also referred to by its drug name, Insulin degludec injection. Your doctor may prescribe another type of insulin or an oral medication such as Metformin to take along with Tresiba.
Tresiba is a long-acting insulin and a human insulin analog. An insulin analog is a synthetic substance very similar to human insulin. Insulin analogs are designed to affect the body more predictably than human insulin does.
How do I take it?
Prescribing information states that Tresiba should be administered via a subcutaneous injection once daily.
Tresiba comes in a prefilled pen.
The FDA-approved label for Tresiba lists common side effects including hypoglycemia (low blood glucose), hypokalemia (low potassium), weight gain, and minor redness or irritation at injection sites.
Rare but serious side effects listed for Tresiba can include hypoglycemia and a systemic allergic reaction.